Patient with hyperthyroidism on carbimazole 15 mg tds came with follow with report tsh 20 what next to do
Reading File
Finding Sources
Finding Sources
Searching the Web
hyperthyroidism carbimazole TSH 20 overtreatment hypothyroidism management dose adjustment
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
I now have all the information needed to give a comprehensive, clinically useful answer.
Clinical Interpretation: TSH = 20 on Carbimazole 15 mg TDS
What Does TSH 20 Mean Here?
A TSH of 20 mU/L (markedly elevated, above normal range of 0.4–4.0 mU/L) in a patient on carbimazole 15 mg three times daily (45 mg/day) — a high dose — indicates iatrogenic/drug-induced hypothyroidism (overtreatment). The carbimazole has over-suppressed thyroid hormone synthesis.
Do NOT interpret this as treatment failure. A suppressed TSH would indicate under-treatment; a high TSH means the opposite — the patient is now hypothyroid from excess antithyroid drug.
Immediate Management
1. Reduce the Carbimazole Dose
The patient's dose is far too high. The maintenance dose in the titration regimen is 2.5–10 mg carbimazole/day. You have two options:
| Approach | Action |
|---|---|
| Titration regimen (preferred) | Reduce carbimazole significantly — step down to 5–10 mg/day (e.g., 5 mg once or twice daily). Recheck TFTs in 4–6 weeks. |
| Block-replace regimen | Keep carbimazole dose constant but add levothyroxine (LT4) to correct hypothyroidism. |
The titration regimen is preferred as it minimizes antithyroid drug exposure and helps gauge response. According to Harrison's 22E:
"The usual daily maintenance doses in the titration regimen are 2.5–10 mg of carbimazole... The titration regimen is often preferred to minimize the dose of antithyroid drug."
2. Check Free T4 (unbound T4) — Not Just TSH
- Free T4 is the primary guide to dose adjustment, especially early in treatment
- TSH can remain suppressed for months after starting treatment, making it unreliable early on — but a high TSH (20) at follow-up clearly indicates overtreatment
- Order: Free T4, Free T3, TSH
3. Assess for Symptoms of Hypothyroidism
Ask about:
- Fatigue, weight gain, cold intolerance, constipation, dry skin
- Bradycardia, puffiness, myalgia
- These confirm clinical hypothyroidism and may warrant temporary LT4 addition
Practical Action Summary
- Stop or substantially reduce carbimazole — from 45 mg/day → reduce to 5–10 mg/day (e.g., carbimazole 5 mg BD or 5 mg OD depending on free T4 level)
- Consider adding low-dose levothyroxine if symptoms of hypothyroidism are present (block-replace approach)
- Recheck TFTs in 4–6 weeks — monitor with free T4 as the primary parameter
- Monitor for relapse once dose is reduced (watch for return of hyperthyroid symptoms)
- Do not stop carbimazole abruptly without TFT confirmation — hyperthyroidism can rebound
Key Principle (Harrison's 22E)
"Thyroid function tests and clinical manifestations are reviewed 4–6 weeks after starting treatment, and the dose is titrated based on unbound T4 levels. Most patients do not achieve euthyroidism until 6–8 weeks after treatment is initiated. TSH levels often remain suppressed for several months and therefore do not provide a sensitive index of treatment response."
In this case, however, TSH = 20 is unequivocal overtreatment — reduce the dose promptly.
Bottom line: TSH of 20 = over-treated → reduce carbimazole to maintenance dose (5–10 mg/day), check free T4, reassess in 4–6 weeks. If symptomatic hypothyroidism, add low-dose levothyroxine temporarily.
This is a shared conversation. Sign in to Orris to start your own chat.